'Promiscuous' expression of tissue antigens in the thymus: A key to T-cell tolerance and autoimmunity?

Journal of Molecular Medicine

Volumn 78, Issue 9, 2000, Pages 483-494

  Klein, Ludger ^a   Kyewski, Bruno ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Promiscuous gene expression; T cell tolerance; Thymus

Indexed keywords

PROTEIN; TISSUE ANTIGEN; UBIQUITIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BLOOD; CELL TYPE; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; NONHUMAN; REVIEW; T LYMPHOCYTE; THYMUS; TISSUE SPECIFICITY;

EID: 0033673148     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000146     Document Type: Review

References (99)

1. T cell tolerance by clonal elimination in the thymus
2. Tolerance in T cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes
3. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen
4. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium
5. Quantitative analysis of the T cell repertoire that escapes negative selection
6. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
7. Peripheral selection of the T cell repertoire
8. Controlling autoreactivity of CD4 T cells by local tolerance induction
9. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells
10. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
11. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens
12. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
13. T cells: A proliferation of costimulatory molecules
14. A cell culture model for T lymphocyte clonal anergy
15. Dendritic cells
16. Distinct levels of peripheral T cell tolerance induced by different doses of antigen
17. Downregulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance
18. Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking
19. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells
20. Conditions that induce tolerance in mature CD4+ T cells
21. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo
22. Modifications of CD8+ T cell function during in vivo memory or tolerance induction
23. Peripheral T cell tolerance: The contribution of permissive T cell migration into parenchymal tissues in the neonate
24. Self-ignorance in the peripheral T cell pool
25. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
26. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
27. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
28. Molecular mimicry and autoimmunity
29. The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset
30. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium
31. CD4+CD8-thymocytes that express L-selection protect rats from diabetes upon adoptive transfer
32. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
33. Control of immune pathology by regulatory T cells
34. Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
35. The third function of the thymus
36. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
37. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
38. Induction of autoimmune diabetes by oral administration of autoantigen
39. Oral tolerance: Mechanisms and therapeutic application
40. Quantitative impact of thymic clonal deletion on the T cell repertoire
41. Self-antigen presentation by thymic stromal cells: A subtle division of labor
42. Peripheral tolerance as a multi-step mechanism
43. A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis
44. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose
45. A functionally compromised intermediate in extrathymic CD8+ T cell deletion
46. The viral triggering of autoimmune disease
47. The shaping of the brain-specific T lymphocyte repertoire in the thymus
48. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein
49. Endogenous myelin basic protein inactivates the high avidity T cell repertoire
50. Shaping of the autoreactive T cell repertoire by a splice variant of self protein expressed in thymic epithelial cells
51. T cell repertoire: Political correctness in the immune system
52. A very high level of cross-reactivity is an essential feature of the T cell receptor
53. Thymic expression of myelin basic protein (MBP). Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP
54. The major myelin protein genes are expressed in the human thymus
55. The thymus and self tolerance: Co-existence of encephalitogenic S100β-specific T cells and their nominal autoantigen in the normal adult rat thymus
56. Pancreatic gene expression in rare cells of thymic medulla: Evidence for functional contribution to T cell tolerance
57. Myelin protein expression in lymphoid tissues: Implications for peripheral tolerance
58. T cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus
59. The thymic repertoire of neuroendocrine self-antigens: Physiological implications in T cell life and death
60. Intrathymic expression of genes involved in organ-specific autoimmune diseases
61. Expression of ocular autoantigens in the mouse thymus
62. Peripheral-antigen-expressing cells in thymic medulla: Factors in self-tolerance and autoimmunity
63. Aberrant expression of tissue-specific proteins in the thymus: A hypothesis for the development of central tolerance
64. Tolerance and autoimmunity to a gastritogenic peptide in TCR transgenic mice
65. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire
66. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice
67. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors
68. The intrathymic expression of insulin-related genes: Implications for pathophysiology and prevention of Type 1 diabetes
69. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83+ dendritic cells express HLA-G as a membrane-bound and soluble protein
70. Expression of thyroid-related genes in human thymus
71. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanism in tolerance towards peripheral antigens
72. Association studies in multiple sclerosis
73. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
74. T cell autoimmunity in multiple sclerosis
75. The role of MHC class II molecules in susceptibility and resistance to autoimmunity
76. Progress in determining the cause and treatment of multiple sclerosis
77. Candidate autoantigens in multiple sclerosis
78. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
79. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease
80. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
81. Diversity and plasticity of self recognition during the development of multiple sclerosis
82. Determinant spreading: Lessons from animal models and human disease
83. T cell recognition of myelin proteolipid protein and myelin proteolipid peptides in the peripheral blood of multiple sclerosis and control subjects
84. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
85. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
86. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease
87. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence
88. Regulation of T cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes
89. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides
90. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis
91. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM 2 locus
92. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes
93. Thymic expression of autoantigens correlates with resistance to autoimmune disease
94. Determinant spreading and immune responses to acetycholine receptors in myasthenia gravis
95. Thymoma
96. APECED: A monogenic autoimmune disease providing new clues to self-tolerance
97. The autoimmune regulator protein has transcriptional transactivating properties and interacts with common co-activator CBP
98. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla
99. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and NOD mouse